---
layout: post
published: FALSE
title: What's new for 'cancer' in PubMed
date: '2011-09-10T13:16:00.002-03:00'
author: Francisco H C Felix
tags:
- Cancer
lang: en-us
ref:
modified_time: '2011-09-18T12:24:40.386-03:00'
blogger_id: tag:blogger.com,1999:blog-2993346515708552092.post-8355065478475138786
blogger_orig_url: https://pharmak.blogspot.com/2011/09/whats-new-for-cancer-in-pubmed.html
---

<div>From Pubmed latest published:<br /><br /><div>Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study. <br />Schaich M,  Röllig C,  Soucek S,  Kramer M,  Thiede C,  Mohr B,  Oelschlaegel U,  Schmitz N,  Stuhlmann R,  Wandt H,  Schäfer-Eckart K,  Aulitzky W,  Kaufmann M,  Bodenstein H,  Tischler J,  Ho A,  Krämer A,  Bornhäuser M,  Schetelig J,  Ehninger G. <br /><span class="jrnl" title="Journal of clinical oncology : official journal of the American Society of Clinical Oncology">J Clin Oncol</span>. 2011 Jul 1;29(19):2696-702. Epub 2011 May 23.<br /><br />This study showed that higher cytarabine dose did not associated with better results than standard dose in AML consolidation chemotherapy. <br />Link: <a href="https://bit.ly/qIuDwd">https://bit.ly/qIuDwd</a></div></div>
